Emerging treatment strategies for glioblastoma multiforme
Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5-year mortality. GBM has a paltry median survival of 12.6 months attributed to the unique treatment limitations such as the high average age of onset, tumor location, and poor current understandings of the tumor...
Main Authors: | Carlsson, Steven K, Brothers, Shaun P, Wahlestedt, Claes |
---|---|
Format: | Online |
Language: | English |
Published: |
BlackWell Publishing Ltd
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237465/ |
Similar Items
-
Therapeutic potential of neuropeptide Y (NPY) receptor ligands
by: Brothers, Shaun P, et al.
Published: (2010) -
Canadian recommendations for the treatment of glioblastoma multiforme
by: Mason, W.P., et al.
Published: (2007) -
Glioblastoma Multiforme
by: Sheehan, Jonas M., et al.
Published: (2012) -
The complement system in glioblastoma multiforme
by: T. A. M. Bouwens van der Vlis, et al.
Published: (2018-09-01) -
Glioblastoma multiforme – an overview
by: Urbańska, Kaja, et al.
Published: (2014)